Table 1.

Patients at high risk of mould infection

Patients at risk of invasive pulmonary aspergillosis
Acute myeloid leukaemia
Allogenic HSCT recipients
Moderate and severe GVHD
Prolonged neutropenia
Other haematological malignancies with biological therapies
SOT recipients (especially heart and lung)
PCNSL receiving ibrutinib
Influenza A (H1N1) infection (especially in immunocompromised patients)

HSCT: haematopoietic stem cell transplantation. GVHD: graft versus host disease. SOT: solid organ transplant. PCNSL: Primary central nervous system lymphoma.